Innovus Pharmaceuticals (INNV): $17.14

0.33 (+1.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

InnovAge Holding Corp (INNV) Price Targets From Analysts

Use the tables below to see what analysts covering InnovAge Holding Corp think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $31 $26 $28.8 $17.37 65.8%

The Trend in the Analyst Price Target


INNV's average price target has moved down $0.45 over the prior 56 days.

INNV reports an average of 33.52% for its upside potential over the past 22 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 5 31 26 28.80 17.66 63.08%
2021-07-10 5 31 26 28.80 20.50 40.49%
2021-07-03 5 31 26 28.80 21.58 33.46%
2021-06-26 5 31 26 28.80 21.06 36.75%
2021-06-13 5 31 26 28.80 21.25 35.53%
2021-06-05 5 31 26 28.80 20.42 41.04%
2021-05-22 4 31 26 29.25 20.65 41.65%
2021-05-15 4 32 26 29.75 21.89 35.91%
2021-05-08 4 32 26 29.75 25.65 15.98%
2021-04-25 4 32 26 29.75 25.35 17.36%
2021-04-17 4 32 26 29.75 24.79 20.01%
2021-04-10 4 32 26 29.75 24.59 20.98%
2019-09-16 1 5 5 5.00 NA NA%

INNV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 3 2 1 0 0 6

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • InnovAge Holding Corp's upside potential (average analyst target price relative to current price) is greater than 76.31% of all US stocks.
  • INNV has a lower variance in analysts' estimates than 75.6% of stocks in the mid market cap category.
  • INNV has a greater number of analysts covering the stock than 30.34% of stocks in the mid market cap category.
  • The average analyst price target of INNV is higher than 36.13% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to InnovAge Holding Corp are XGN, DMTK and AKU.

Is INNV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7454 seconds.